In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum

Adhikari, 2015, Structural findings of phenylindoles as cytotoxic antimitotic agents in human breast cancer cell lines through multiple validated QSAR studies, Toxicol. in Vitro, 29, 1392, 10.1016/j.tiv.2015.05.017 Albanese, 2010, Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy, Mol. Cancer Ther., 9, 2243, 10.1158/1535-7163.MCT-10-0190 Arranz-Solis, 2015, Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model, Vet. Parasitol., 211, 133, 10.1016/j.vetpar.2015.05.021 Brasca, 2009, Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-py razolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitor, J. Med. Chem., 52, 5152, 10.1021/jm9006559 Buxton, 2002, The comparative pathogenesis of neosporosis, Trends Parasitol., 18, 546, 10.1016/S1471-4922(02)02414-5 Caporali, 2010, The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound, Pharmacol. Res., 61, 437, 10.1016/j.phrs.2009.12.009 Castellanos-Gonzalez, 2016, A novel calcium-dependent kinase inhibitor, bumped kinase inhibitor 1517, cures cryptosporidiosis in immunosuppressed mice, J. Infect. Dis., 214, 1850, 10.1093/infdis/jiw481 Debache, 2008, Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites, Int. J. Parasitol., 38, 1455, 10.1016/j.ijpara.2008.04.001 Doggett, 2012, Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis, Proc. Natl. Acad. Sci. U.S.A., 109, 15936, 10.1073/pnas.1208069109 Dubey, 2003, Review of Neospora caninum and neosporosis in animals, Korean J. Parasitol., 41, 1, 10.3347/kjp.2003.41.1.1 Häsler, 2006, Simulating the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle, Prev. Vet. Med., 77, 254, 10.1016/j.prevetmed.2006.07.007 Hemphill, 2016, Approaches for the vaccination and treatment of Neospora caninum infections in mice and ruminant models, Parasitology, 143, 245, 10.1017/S0031182015001596 Hines, 2015, Theileria equi isolates vary in s usceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor, Parasites Vectors, 8, 33, 10.1186/s13071-014-0611-6 La Regina, 2015, New indole tubulin assembly inhibitors cause stable arrest of mitotic progression, enhanced stimulation of natural killer cell cytotoxic activity, and repression of hedgehog-dependent cancer, J. Med. Chem., 58, 5789, 10.1021/acs.jmedchem.5b00310 Lawres, 2016, Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone, J. Exp. Med., 213, 1307, 10.1084/jem.20151519 Müller, 2017, Two novel calcium-dependent kinase 1-inhibitors interfere with vertical transmission in mice infected with Neospora caninum tachyzoites, Antimicrob. Agents Chemother., 61, e02324, 10.1128/AAC.02324-16 Müller, 2015, Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice, Int. J. Parasitol.: Drugs Drug Res., 5, 16 Müller, 2016, Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model, Vet. Res., 47, 32, 10.1186/s13567-016-0317-1 Müller, 2015, In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts, Int. J. Antimicrob. Agents, 46, 88, 10.1016/j.ijantimicag.2015.02.020 Müller, 2013, New approaches for the identification of drug targets in protozoan parasites, Int. Rev. Cell. Mol. Biol., 301, 359, 10.1016/B978-0-12-407704-1.00007-5 Nilsen, 2014, Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers, J. Med. Chem., 57, 3818, 10.1021/jm500147k Ojo, 2016, Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy, Int. J. Parasitol., 46, 871, 10.1016/j.ijpara.2016.08.003 Ojo, 2010, Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors, Nat. Struct. Mol. Biol., 17, 602, 10.1038/nsmb.1818 Ojo, 2012, Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors, J. Clin. Invest., 122, 2301, 10.1172/JCI61822 Ojo, 2014, Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy, PLoS One, 9, e92929, 10.1371/journal.pone.0092929 Pedroni, 2016, Bumped kinase inhibitor prohibits egression in Babesia bovis, Vet. Parasitol., 215, 22, 10.1016/j.vetpar.2015.10.023 R Core Team, 2012. R: A Language and Environment for Statistical Computing. Reichel, 2013, What is the global economic impact of Neospora caninum in cattle - the billion dollar question, Int. J. Parasitol., 43, 133, 10.1016/j.ijpara.2012.10.022 Schaefer, 2016, Novel bumped kinase inhibitors are safe and effective therapeutics in the calf clinical model for cryptosporidiosis, J. Infect. Dis., 214, 1856, 10.1093/infdis/jiw488 Stickles, 2015, Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum, Antimicrob. Agents Chemother., 59, 1977, 10.1128/AAC.04149-14 Stickles, 2015, Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy, Am. J. Trop. Med. Hyg., 92, 1195, 10.4269/ajtmh.14-0553 Van Voorhis, 2016, Open source drug discovery with the malaria box compound collection for neglected diseases and beyond, PLoS Pathog., 12, e1005763, 10.1371/journal.ppat.1005763 Vidadala, 2016, Development of an orally available and central nervous system (CNS) penetrant Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitor with minimal human Ether-a-go-go-Related Gene (hERG) activity for the treatment of toxoplasmosis, J. Med. Chem., 59, 6531, 10.1021/acs.jmedchem.6b00760 Winter, 2011, Optimization of endochin-like quinolones for antimalarial activity, Exp. Parasitol., 127, 545, 10.1016/j.exppara.2010.10.016 Winzer, 2015, In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum, Antimicrob. Agents Chemother., 59, 6361, 10.1128/AAC.01236-15